Skip to main content
. 2019 Aug 2;9:11231. doi: 10.1038/s41598-019-47755-8

Figure 2.

Figure 2

Endogenous and post-transfection expression levels of NOVA1. (A) Endogenous expression of NOVA1 protein and predicted target miRs in the HPV-negative non-oropharynx SCC cell lines FaDu and CAL27 and the HPV-positive oropharynx SCC cell line UMSCC47. FaDu cells show the highest endogenous expression levels of NOVA1, miR-146a-5p, and miR-146b-5p. Fold changes in each molecule were calculated in comparison to UMSCC47. (B) After 24 hours of transfection of poly(dA:dT) double-stranded DNA in FaDu cells, a dose-dependent increase in NOVA1 expression was noted. (C) After 24-hour transfection into FaDu cells, NOVA1 levels were the lowest when treating with miR-146b mimic, but the highest when treating with poly(dA:dT) + anti-miR-146b-5p. When treating with miR-146b mimic, adding poly(dA:dT) did not significantly increase NOVA1 expression. Fold changes in NOVA1 were calculated in comparison to cells treated with scramble.